Geode Capital Management, LLC Aquestive Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,576,972 shares of AQST stock, worth $8.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,576,972
Previous 538,456
192.87%
Holding current value
$8.07 Million
Previous $2.29 Million
78.81%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
43.1MCall Options Held
271KPut Options Held
212K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$50.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$28.4 Million1.58% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.23MShares$21.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.85MShares$14.6 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $273M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...